Evaluate the Effects of Citicoline on Mood in Healthy Adults
← catalyst calendarSponsored by Kirin Holdings Company, Limited (industry) · 2503.T — their whole pipeline →. With The Center for Applied Health Sciences, LLC.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · Triple · Health services research
Enrollment
90estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-07-31 | actual | When the study began enrolling |
| Primary completion | 2026-03-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-03-31 | estimated | The whole study's end, after follow-up |
| First posted | 2025-07-28 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-02 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy
Interventions
- Dietary supplement: Citicoline
- Dietary supplement: Placebo
Primary outcome
what the primary-completion date above is the date OFTotal Mood Disturbance (TMD) score on the Profile of Mood States second eddition-Adult short (POMS2)
measured 4 weeks
Permalink · 2503.T's whole pipeline · Catalyst calendar · Every registered study · What changed